Therefore, we aimed to elucidate the applicability of VCS parameters as potential predictors for infections in patients with cirrhosis and compare their reliability with traditional inflammatory biomarkers such as PCT, IL-6, and soluble hemoglobin clearance receptor (sCD163). The gene discussed is CD163; the disease is Cirrhosis.